NEW THERAPY OFFERS HOPE FOR BONE MARROW CANCER

Published:2019-05-03


A new therapy developed by Chinese researchers to treat bone marrow cancer has completed its first phase of clinical trials with a response rate of 90 percent.


The high response rate suggests the therapy might significantly raise the five-year survival rate of patients with multiple myeloma, which currently stands at 50.7 percent.

SITE MAP

World Time

  • SENEGAL | DAKAR:07.14 21:27

  • NIGERIA | LAGOS:07.14 22:27

  • EGYPT | CAIRO:07.14 23:27

  • UAE | DUBAI:07.15 01:27

  • SRI LANKA | COLOMBO:07.15 02:57

  • SINGAPORE:07.15 05:27

  • ENGLAND | LONDON:07.14 22:27

  • RUSSIA | MOSCOW:07.15 01:27

  • CHINA | BEIJING:07.15 05:27

  • AMERICA | Los Angels:07.14 14:27

  • AMERICA | New York:07.14 17:27

  • BRAZIL | San Paulo:07.14 18:27